Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lumry

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Allergy and Asthma Proceedings|August 4, 2012
Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacksJ Andrew Grant, Martha V White, H Henry Li, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1984
Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirinD D Stevenson, W W Pleskow, R A Simon, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2025
Garadacimab in hereditary angioedema due to normal C1INH with F12/PLG mutationsDanny M Cohn, Avner Reshef, Petra Staubach, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 7, 2023
Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedemaWilliam R Lumry, Marcus Maurer, Karsten Weller, et al.
Drug Design, Development and Therapy|July 8, 2026
Donidalorsen for the Treatment of Hereditary Angioedema: A Review of Clinical StudiesMarc A Riedl, Timothy Craig, William R Lumry, et al.
Allergy and Asthma Proceedings|March 17, 2026
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxisMark Davis-Lorton, Daniel Soteres, William R Lumry, et al.
International Archives of Allergy and Immunology|July 17, 2025
Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More YearsWilliam R Lumry, Mark Davis-Lorton, Daniel Soteres, et al.
Allergy and Asthma Proceedings|December 27, 2023
An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapyWilliam R Lumry, Jonathan A Bernstein, Henry H Li, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 31, 2006
Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroidsWilliam R Lumry, Michael M Conway, Craig F LaForce, et al.
Frontiers in Immunology|July 26, 2021
Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary ImmunodeficienciesElena E Perez, Jacques Hébert, Anne K Ellis, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Allergy and Asthma Proceedings|August 4, 2012
Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacksJ Andrew Grant, Martha V White, H Henry Li, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1984
Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirinD D Stevenson, W W Pleskow, R A Simon, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2025
Garadacimab in hereditary angioedema due to normal C1INH with F12/PLG mutationsDanny M Cohn, Avner Reshef, Petra Staubach, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 7, 2023
Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedemaWilliam R Lumry, Marcus Maurer, Karsten Weller, et al.
Drug Design, Development and Therapy|July 8, 2026
Donidalorsen for the Treatment of Hereditary Angioedema: A Review of Clinical StudiesMarc A Riedl, Timothy Craig, William R Lumry, et al.
Allergy and Asthma Proceedings|March 17, 2026
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxisMark Davis-Lorton, Daniel Soteres, William R Lumry, et al.
International Archives of Allergy and Immunology|July 17, 2025
Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More YearsWilliam R Lumry, Mark Davis-Lorton, Daniel Soteres, et al.
Allergy and Asthma Proceedings|December 27, 2023
An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapyWilliam R Lumry, Jonathan A Bernstein, Henry H Li, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 31, 2006
Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroidsWilliam R Lumry, Michael M Conway, Craig F LaForce, et al.
Frontiers in Immunology|July 26, 2021
Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary ImmunodeficienciesElena E Perez, Jacques Hébert, Anne K Ellis, et al.
Pageof 14